vitiligo
VITILIGO
Vitiligo is an acquired, often familial, melanocytopenic disorder that produces focal depigmentation of the skin.
About half of the patients has onset of lesion before the age of 20.
It is a progressive disease wherein spontaneous repigmentation may occur within 6 months.
Precipitating factors include emotional stress, sunburn, chemical exposure, skin trauma, inflammation, irritation or rash that may precede the lesions by 2-3 months.
Lesions are white-colored macules or patches with well-defined borders and otherwise normal skin surface.

Follow Up

Nonsegmental Vitiligo

  • NSV patients on narrow band UVB therapy should be reassessed on the 3rd & 6th mth of therapy
  • If still w/ disease progression after 3 mth of narrow band UVB therapy w/ topical steroid/calcineurin inhibitor therapy, consider switching to systemic corticosteroid therapy
    • After 3-6 mth, consider surgical interventions if disease is stable but w/o repigmentation, or depigmentation therapy if w/o repigmentation & w/ Koebner phenomenon
    • After 9 mth of narrow band UVB treatment, consider surgical interventions if disease is stable but repigmentation stopped

Segmental Vitiligo

  • Reassess patients on topical steroids & calcineurin inhibitors on the 6th mth of therapy
Editor's Recommendations
Most Read Articles
6 days ago
Being overweight or obese in adolescence appears to increase the risk of papillary thyroid cancer in adulthood, a recent study has shown.
2 days ago
A recent study reports a mean growth rate of proximal aorta of about 0.1 mm/year in hypertensive patients with known aortic dilatation. In addition, those with increased rather than normal aortic z score have slower dilatation over time.
Tristan Manalac, Yesterday
The coronavirus disease 2019 (COVID-19) appears to be more dangerous among cancer patients, who tend suffer more severe complications and faster disease progression, according to a new study.
6 days ago
Knee osteoarthritis (OA), whether symptomatic or radiographic, contributes to an increased risk of all-cause mortality, with the risk increase from symptomatic knee OA partially attributed to its effect on disability and quality of life (QoL).